期刊文献+

凝血/纤溶指标与急诊社区获得性肺炎患者院内死亡风险相关性分析 被引量:1

The analysis of the correlation between coagulation / fibrinolysis index and risk of death in emergency patients with community-acquired pneumonia
下载PDF
导出
摘要 目的研究凝血/纤溶指标与急诊社区获得性肺炎(CAP)患者院内死亡风险的相关性。方法收集中国医科大学附属第一医院急诊科2010年8月至2013年8月期间患社区获得性肺炎患者96例,排除恶性肿瘤、活动性肺结核、血液系统疾病、确诊或疑诊的肺栓塞、免疫功能抑制、长期使用抗凝药、皮质激素和抗血小板药物、孕妇以及实验室检查不全者。根据是否院内死亡,将患者分为死亡组和存活组。分析两组患者年龄、性别及急诊首次静脉血白细胞计数(WBC)、血小板计数(PLT)、凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、国际标准化比值(INR)、纤维蛋白原(FIB)、D二聚体(D-D)、血谷丙转氨酶(ALT)、白蛋白(ALB)、总胆红素(TBIL)、尿素氮(BUN)、肌酐(CR)、脑钠肽(BNP)、血糖等。将上述单因素分析得出的显著性因素(P〈0.1)进行多因素Logistic回归分析,以P〈0.05为差异有统计学意义。进一步对多因素分析得出的独立危险因素绘制受试者工作曲线(ROC),并计算ROC曲线下面积(AUC)、截断值、灵敏度、特异度、95%可信区间,AUC进行Pairwise检验。结果与存活组比较,死亡组的Cr[73(60-120)μmol/L∶61(49-53)μmol/L,P=0.032]、PT[14.7(13.0-17.8)s∶14.1(13.5-15.0)s,P=0.055]、INR[1.18(1.05-1.50)∶1.11(1.02-1.21),P=0.009]、D-D[5.5(2.0-20.0)μg/ml∶2(1-4)μg/ml,P=0.000]均明显升高。Logistic回归多因素分析结果显示:D-D(β=0.220,OR=1.246,P=0.000)、INR(β=3.646,OR=38.32,P=0.047)为CAP患者院内死亡的独立危险因素。将独立危险因素绘制ROC曲线,AUC由大到小分别为:D-D×INR(0.770)、INR(0.760)和D-D(0.742)。Pairwise检验结果显示:PT、INR及D-D×INR的ROC曲线AUC之间无显著性差异。当D-D×INR的截断值为3.82时,敏感度为0.750,特异度为0.691。结论凝血/纤溶指标中除了D-D之外,INR也可以用于急诊CAP患者院内死亡的风险评估。 Objective To investigate the correlation between coagulation/fibrinolysis indexes and risk of death in emergency department(ED) patients with community-acquired pneumonia(CAP). Methods Totally 96 patients with CAP in ED of the First Hospital of China Medical University from August 2010 to August 2013 were studied retrospectively, excluding those with malignant tumour, avtive tuberculosis,hematopoietic disease, documented or suspected pulmonary embolism,immunosuppression,long-term usage of anticoagn lants, glucocorticosteroids and antiplatelet drugs,pregnant,laboratory tests deficiency. All cases were divided into survival group and non-survival group according to whether they died or not in hospital. Age, sex, white blood cell ( WBC ), platelet count ( PLT), prothrombin time (PT), activated partial thromboplastin time (APTI'), international normalized ratio (INR), fibrinogen ( FIB ), D-Dimer ( D-D ), glutamic- pyruvic transaminase enzyme (GPT), albumin (ALB), total bilirubin (TBil), urea nitrogen (BUN), creatinine (Cr), brain natriuretic peptide(BNP) ,glucose(GLU) and arterial blood gases (ABG) were analyzed. The measurement data with Gaussian distribution was described with x + s deviation and groups were compared with t-test. The measurement data with abnormal distribution was described with median( quartile range) and groups were compared with non-parametric rank-sum test. In single-factor analysis,P 〈 0.1 was considered to be have significant difference. These significances were analized with multiple-factor analysis,and P 〈0.05 was considered to be have significant difference. Receiver operating characteristic (ROC) curves were drawn and areas under ROC curve (AUC), cut -off value, sensitivity and specificity were calculated. Results Compared with suvivals,non-survivals Cr[73(60-120)Ixmol/L vs 61 (49-53)μmol/ L,P =0.032] ,PT[14.7(13.0-17.8) seconds vs 14. 1(13.5-15.0) seconds,P =0.0551 ,INR [1.18(1.05-1.50) vs 1.11(1.02- 1.21 ), P = 0.009 ], D-D [ 5.5 (2.0-20.0) μg/ml vs 2 ( 1-4 ) μg/ml, P = 0. 000 ] were significantly elevated. Analyze P 〈 0. 10 factors with Logistic regression multiple-factor analysis: D-D ( 13 = 0. 220, OR = 1. 246, P = 0), INR ( 13 = 3. 646, OR = 38.32, P = 0. 047 ) were the independent risk factors of death in hospital. Draw ROC curves and AUG is: D-D × INR(0.770), INR (0.760), D-D (0.742). When cutoff value of D-D × INR was 3.82, sensitivity was 0.750, specificity was 0.691. Conclusion Not only D-D is one indicator of the coagnlation/fibrinolys indexes,but also INR can be used for assessing the risk of death in ED patients with CAP.
作者 崇巍 段蒙新
出处 《临床军医杂志》 CAS 2015年第8期774-777,共4页 Clinical Journal of Medical Officers
基金 辽宁省自然科学基金(201202289)
关键词 社区获得性肺炎 D二聚体 国际标准化值 Community-acquired pneumonia(CAP) D-Dimer(D-D) International normalized ratio(INR)
  • 相关文献

参考文献14

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3065
  • 2Torres A, Peetermans WE, Viegi G, et al. Risk factors for eommu- nityacquired pneumonia in adults in Eumpe:a literature review[ J ]. Thorax ,2013,68 ( 11 ) : 1057-1065.
  • 3Millett ER, Quint JK, Smeeth L, et al. Incidence of communityac- quired lower respiratory tract infections and pneumonia among ol- der adults in the United Kingdom:a population-based study [ J]. PLoS One,2013,8(9) :e75131.
  • 4Stolz D, Christ-Crain M, Gencay MM, et al. Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract in- fection[ J]. Swiss Med Wkly ,2006,136:434-440.
  • 5Fernandez JF, Sibila O, Restrepo MI, et al. Predicting ICU admis- sion in community-acquired pneumonia: clinical scores and bio- markers[ J]. Expert Rev Clin Pharmacol,2012 ,5 :445-458.
  • 6Vail GM, Xie Y J, Haney D J, et al. Biomarkers of thrombosis,fibfi- nolysis, and inflammation in patients with severe sepsis due to community-acquired pneumonia with and without Streptococcus pneumoniae [ J ]. Infection,2009 ; 37 : 358 -364.
  • 7Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflam- mation in disease[ J]. Semin Immunopathol,2011,34 :43-62.
  • 8王红,张淑文,任爱民,张丽霞,王超,黄樱,苏艳丽,王宝恩.重度脓毒症凝血功能紊乱与病情严重度及预后的关系[J].中华急诊医学杂志,2005,14(10):804-806. 被引量:54
  • 9Milbrandt EB, Reade MC, Lee M, et al. Prevalence and signifi- cance of coagulation abnormalities in community-acquired pneu- monia[ J]. Mol Med ,2009,15:438-445.
  • 10Arslan S, Ugurlu S, Bulut G, et al. The association between plas- ma D-dimer levels and community-acquired pneumonia[ J ]. Clin- ics ,2010,65:593-597.

二级参考文献44

  • 1沈定霞,罗燕萍,崔岩,赵莉萍,白立彦.分离产金属β-内酰胺酶的铜绿假单胞菌[J].中华医院感染学杂志,2004,14(1):86-88. 被引量:109
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:789
  • 3King DE, Pippin HJ Jr. Community - acquired pneumonia in adults: initial antibiotic therapy[J]. Am FAM Physician, 1997, 56(2):544.
  • 4Assiscot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection[J]. Lancet, 1993,341 : 515-518.
  • 5Casado FJ ,Blanco QA. Procalcitnin, a new marker for bacterial infection[J]. An Esp pediatr,2001,54:69.
  • 6Masia M, Guti arez F, Shum C, et al. Usefulness of proealeitonin levels in community - acquired pneumonia according to the patients outcome research team pneumonia severity index[ J ]. Chest,2005,128(4) : 2223 - 2229.
  • 7Querol Ribelles JM,Tenias JM, Grau E, et al. Plasma D - dimer levels correlate with outcome in patients with community - acquired pneumonia[J ]. Chest, 2004,126 : 1087 - 1092.
  • 8Chalmers JD, Singanayagam A, Hill AT. C- reactive protein is an independent predictor of severity in community- acquired pneumonia[J]. Am J Med, 2008,121 : 219 - 225.
  • 9American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med,1992, 20 (6): 864- 874.
  • 10Marshall JC, Cook DJ, Christou NV, et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med, 1995, 23 (10): 1638- 1652.

共引文献3143

同被引文献11

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部